Relaxin protects against myocardial injury caused by ischemia and reperfusion in rat heart

American Journal of Pathology

Volumn 152, Issue 5, 1998, Pages 1367-1376

  Bani, Daniele ^a,c   Masini, Emanuela ^a   Bello, Maria Grazia ^a   Bigazzi, Mario ^b   Bani Sacchi, Tatiana ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Prosperius Institute   (Italy)

^c Sezione di Istologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; MALONALDEHYDE; MEMBRANE LIPID; MYELOPEROXIDASE; RELAXIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; ENZYME ACTIVITY; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; INTRAVENOUS DRUG ADMINISTRATION; LIPID PEROXIDATION; MALE; MAST CELL; MICROSCOPY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; THROMBOCYTE ACTIVATION;

ANIMALS; ARRHYTHMIA; CALCIUM; CYTOPLASMIC GRANULES; ELECTROCARDIOGRAPHY; HEART VENTRICLES; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS, INTRAVENOUS; MALE; MALONDIALDEHYDE; MAST CELLS; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NEUTROPHILS; PEROXIDASE; RATS; RATS, WISTAR; RELAXIN; SURVIVAL ANALYSIS;

EID: 0031945701     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Van Benthuysen KM, McMurtry IF, Horwitz LD: Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest 1978, 79:265-274
2. Ku DD: Coronary vascular reactivity after acute myocardial ischemia. Science 1982, 218:576-578
3. Braunwald E, Kloner R: Myocardial reperfusion: a double edged sword. J Clin Invest 1985, 76:1713-1719
4. Nichols WW, Mehta JL, Donnelly WH, Lawson D, Thompson L, Menno TR: Reduction in coronary vasodilator reserve following coronary occlusion and reperfusion in anesthetized dog: role of endothelium-derived relaxing factor, myocardial neutrophil infiltration and prostaglandins. J Mol Cell Cardiol 1988, 20:943-954
5. Lefer AM, Tsao PS, Lefer DJ, Ma X-I: Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J 1991, 5:2029-2034
6. Senoh M, Aosaki N, Ohsuzu F, Nakamura H, Minezaki K, Tuji C, Nakazawa H: Early release of neutrophil chemotactic factor from isolated rat heart subjected to regional ischemia followed by reperfusion. Cardiovasc Res 1993, 27:2194-2199
7. Harlan JM: Leukocyte-endothelial interactions. Blood 1985, 65:513-525
8. May GR, Crook P, Moore PK, Page CP: The role of nitric oxide as an endogenous regulator of platelet and neutrophil activation within the pulmonary circulation of the rabbit. Br J Pharmacol 1991, 102:759-763
9. Engler RL, Dahlgren MD, Morris D, Peterson MA, Schmid-Schönbein GW: Role of leukocytes in the response to acute myocardial ischemia and reflow in dogs. Am J Physiol 1986, 251:H314
10. Cohen MV: Free radicals in ischemic and reperfusion myocardial injury: is this the time for clinical trials? Ann Intern Med 1989, 111: 918-931
11. Müllane KM: Myocardial ischemia-reperfusion injury: role of neutrophils and neutrophil-derived mediators. Current Concepts in Immunology. Clinical Immunology: Human Inflammatory Disease, vol 1. Edited by MG Burlinghton, Ontario, Canada, BC Decker, 1988, pp 143-159
12. McCord JM: Oxygen-derived free radicals in post-ischemic tissue injury. N Engl J Med 1985, 312:159-163
13. Keller AM, Clancy RM, Barr ML, Marboe CC, Cannon PJ: Acute reoxygenation injury in the isolated rat heart: role of resident cardiac mast cells. Circ Res 1988, 63:1044-1052
14. Masini E, Blanchi S, Gambassi F, Palmerani B, Pistelli A, Carlomagno L, Mannaioni PF: Ischemia reperfusion injury and histamine release in isolated and perfused guinea-pig heart: pharmacological interventions. Agents Actions 1990, 30:198-201
15. Zimmerman GA, Prescott SM, McIntyre TM: Endothelial cell interactions with granulocytes; tethering and signaling molecules. Immunol Today 1992, 13:93-100
16. Wolff AA, Levi R: Histamine and cardiac arrhythmias. Circ Res 1986, 58:1-16
17. Parratt JR: Endogenous myocardial protective (antiarrhythmic) substances. Cardiovasc Res 1993, 27:693-702
18. Bani D: Relaxin: a pleiotropic hormone. Gen Pharmacol 1997, 28: 13-22
19. Bani Sacchi T, Bigazzi M, Bani D, Mannaioni PF, Masini E: Relaxin-induced increased coronary flow through stimulation of nitric oxide production. Br J Pharmacol 1995, 116:1589-1594
20. Bani D, Bigazzi M, Masini E, Bani G, Bani Sacchi T: Relaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit platelets. Lab Invest 1995, 73:709-715
21. Masini E, Bani D, Bigazzi M, Mannaioni PF, Bani Sacchi T: Effects of relaxin on mast cells: in vitro and in vivo studies in rats and guinea pigs. J Clin Invest 1994, 94:1974-1980
22. Sherwood OD, O'Byrne EM: Purification and characterization of porcine relaxin. Arch Biochem Biophys 1974, 60:185-196
23. Weiss G, O'Byrne EM, Hochman JA, Goldsmith LT, Rifkin I, Steinetz BG: Secretion of progesterone and relaxin by the human corpus luteum at midpregnancy and at term. Obstet Gynecol 1977, 50:679-681
24. Klein HH, Puschmann S, Schaper J, Schaper W: The mechanism of the tetrazolium reaction in identifying experimental myocardial infarction. Virchows Arch A 1981, 393:287-297
25. Dieterich HA, Löffelholz K: Effect of coronary perfusion rate on the hydrolysis of exogenous and endogenous acetylcholine in the isolated heart. Naunyn-Schmiedebergs Arch Exp Pathol Pharmakol 1977, 296:143-148
26. Fujimoto T, Peter T, Hamamoto H, Mandel WJ: Electrophysiologic observations on ventricular tachyarrhythmias following reperfusion. Am Heart J 1983, 105:201-209
27. Gelvan D, Saltman P, Powell GR: Cardiac reperfusion damage prevented by a nitroxide free radical. Proc Natl Acad Sci USA 1991, 88:4680-4684
28. Bradley PP, Priebat DA, Christensen RD, Rothstein G: Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982, 78:206-209
29. Müllane KM, Kraemer R, Smith B: Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985, 14:157-167
30. Griswold DE, Hillegass L, Hill DE, Sherief HT, Kopia GA: Evaluation of the effect of Evan's blue and tripheniltetrazolium dyes on myeloperoxidase activity in canine cardiac tissue. J Pharmacol Methods 1989, 21:13-19
31. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254
32. Rao DS, Cohen MV, Muller HS: Production of free radicals and lipid peroxidation in early experimental myocardial ischemia. J Mol Cell Cardiol 1983, 15:713-714
33. Aruoma OI, Halliwell B, Laughton MJ, Quinlan GJ, Gutteridge JMC: The mechanism of initiation of lipid peroxidation: evidence against a requirement for an iron (II)-iron (III) complex. Biochem J 1989, 258: 617-620
34. Bourdillon PDV, Poole-Wilson PA: Effects of ischemia and reperfusion on calcium exchange and mechanical function in isolated rabbit myocardium. Cardiovasc Res 1981, 15:121-130
35. Masini E, Gambassi F, Giannella E, Palmerani B, Pistelli A, Carlomagno L, Mannaioni PF: Ischemia-reperfusion injury and histamine release in isolated guinea-pig heart: the role of free radicals. Agents Actions 1989, 27:154-157
36. Trudeau DL, Freier EF: Determination of calcium in urine and serum by atomic absorption spectrophotometry (AAS). Clin Chem 1967, 13:101-114
37. Kolodgie FD, Virmani R, Farb A, Hart CL: Limitation of no reflow injury by blood-free reperfusion with oxygenated perfluorochemical (FluosolDA 20%). J Am Coll Cardiol 1991, 18:215-223
38. Bianchi S, Mugnai L: Mast cell fixation and staining in image analysis. Eur J Basic Appl Histochem 1991, 35:161-174
39. Smith EE, Egan JW, Bugelski PJ, Hillegass IM, Hill DE, Griswold DE: Temporal relation between neutrophil accumulation and myocardial reperfusion injury. Am J Physiol 1988, 255:H1060-H1068
40. Reynolds JM, McDonagh PF: Early in reperfusion, leukocytes alter perfused coronary capillarity and vascular resistance. Am J Physiol 1989, 256:H982-H983
41. Crawford MH, Grover FL, Colb WP, McMahan A, O'Rourke RA, McManus LM, Pinckard RN: Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation 1988, 78: 1449-1458
42. Ovize M, de Lorgeril M, Cathignol D, Delaye J, Renaud S: Inhibition of coronary artery thrombosis by SIN-1, a donor of nitric oxide. J Cardiovasc Pharmacol 1990, 16:641-645
43. Zimmerman ANE, Hulsman WC: Paradoxical influence of calcium ions on the permeability of the cell membranes of the isolated rat heart. Nature 1966, 211:646-647
44. Ashraf M, Onda M, Benedict JB, Millard RW: Prevention of calcium paradox-related myocardial cell injury with diltiazem, a calcium channel blocking agent. Am J Cardiol 1982, 49:1675-1681
45. Ganote CE, Nayler WG: Contracture and the calcium paradox. J Mol Cell Cardiol 1985, 17:733-745
46. Duncan E, Onodera T, Ashraf M: Production of hydroxyl radicals and their disassociation from myocardial cell injury during calcium paradox. Free Radical Biol Med 1992, 12:11-18
47. Bani D, Failli P, Bello HG, Thiemermann C, Bani Sacchi T, Bigazzi M, Masini E: Relaxin activates the L-arginine-nitric oxide pathway in vasuclar smooth muscle cells in culture. Hypertension 1998, 31 (in press)
48. Bani D, Maunzi M, Bigazzi M: Relaxin reduces the number of circulating platelets and depresses platelet release from megakaryocytes: studies in rats. Platelets 1995, 6:330-335
49. Austen KF: The heterogeneity of mast cell population and products. Hosp Pract 1984, 19:135-146
50. Schwartz LB, Austen KF: Structure and function of the chemical mediators of mast cells. Prog Allergy 1984, 34:271-321
51. Thiemermann C, Steinhagen-Thiessen E, Schror K: Inhibition of oxygen centred free radical formation by the stable prostacyclin-mimetic iloprost (ZK 36374) in acute myocardial ischemia. J Cardiovasc Pharmacol 1984, 6:365-366
52. Herbaczynsko-Cedro K, Gordon-Majszak W: Attenuation by prostacyclin of adrenaline-stimulated lipid peroxidation in the myocardium. Pharmacol Res Commun 1986, 81:321-332
53. Kowey PR, Verrier RL, Lown B, Handin RI: Influence of intracoronary platelet aggregation on ventricular electrical properties during partial coronary artery stenosis. Am J Cardiol 1983, 51:596-602
54. Sherwood OD, Crnekovio VE, Gordon WL, Rutherford JE: Radioimmunoassay of RLX throughout pregnancy and during parturition in the rat. Endocrinology 1980, 107:691-698
55. Bell RJ, Eddie LW, Lester AR, Wood EC, Johnston PD, Niall HD: Relaxin in human pregnancy serum measured with an homologous radioimmunoassay. Obstet Gynecol 1987, 69:585-589
56. Stewart DR, Celniker AC, Taylor CA, Cragun JR, Overstreet JW, Lasley BL: Relaxin in the peri-implantation period. J Clin Endocrinol Metab 1990, 70:1771-1773
57. Kannel WB, Abbott RD: Incidence and prognosis of myocardial infarction in women: the Framingham study. Coronary heart disease in women. Edited by ED Eaker, B Packard, NK Wenger, TB Clarkson, HA Tyroler. New York, Haymarket-Doyma, 1987, pp 208-214.
58. Manson JE, Tosteson H, Ridker PM, Satterfield S, Hebert P, O'Connor GT, Buring JE, Hennekens CH: The primary prevention of myocardial infarction. N Engl J Med 1992, 326:1406-1416